Zum Hauptinhalt springen Zur Suche springen Zur Hauptnavigation springen
Beschreibung
Medicines generate their most important evidence after they enter real-world use, where patterns of exposure, treatment outcomes, safety signals and healthcare costs must be interpreted at population level. Written for Pharm.D students , this book develops the principles needed to evaluate medicine use, risk and economic value with methodological and clinical relevance.
The pharmacoepidemiology section progresses from outcome and drug-use measures, medication adherence and risk estimation to study designs, drug-utilisation review, meta-analysis, spontaneous reporting, prescription event monitoring and major healthcare data sources. The pharmacoeconomics section examines cost concepts, clinical, economic and humanistic outcomes, QALY and DALY, major economic evaluation methods, ICER, budget impact, formulary decision-making and the use of analytical software and decision models.
Worked calculations, synthetic case scenarios, model answers and structured revision material reinforce interpretation rather than formula memorisation. By linking epidemiological reasoning with cost-outcome analysis and formulary decisions, the book supports systematic learning, quantitative competence and the professional judgement required in clinical pharmacy, drug-safety evaluation and healthcare resource allocation.
Medicines generate their most important evidence after they enter real-world use, where patterns of exposure, treatment outcomes, safety signals and healthcare costs must be interpreted at population level. Written for Pharm.D students , this book develops the principles needed to evaluate medicine use, risk and economic value with methodological and clinical relevance.
The pharmacoepidemiology section progresses from outcome and drug-use measures, medication adherence and risk estimation to study designs, drug-utilisation review, meta-analysis, spontaneous reporting, prescription event monitoring and major healthcare data sources. The pharmacoeconomics section examines cost concepts, clinical, economic and humanistic outcomes, QALY and DALY, major economic evaluation methods, ICER, budget impact, formulary decision-making and the use of analytical software and decision models.
Worked calculations, synthetic case scenarios, model answers and structured revision material reinforce interpretation rather than formula memorisation. By linking epidemiological reasoning with cost-outcome analysis and formulary decisions, the book supports systematic learning, quantitative competence and the professional judgement required in clinical pharmacy, drug-safety evaluation and healthcare resource allocation.
Details
Erscheinungsjahr: 2026
Fachbereich: Unterricht
Genre: Erziehung & Bildung, Importe
Rubrik: Sozialwissenschaften
Medium: Taschenbuch
ISBN-13: 9798906732316
Sprache: Englisch
Einband: Kartoniert / Broschiert
Autor: Ghosh Payel
Gundimeda Sandhya Vani
Avanigadda Meghana
Hersteller: Notion Press
Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, D-36244 Bad Hersfeld, gpsr@libri.de
Maße: 229 x 152 x 18 mm
Von/Mit: Ghosh Payel (u. a.)
Erscheinungsdatum: 24.08.2026
Gewicht: 0,485 kg
Artikel-ID: 136341808

Ähnliche Produkte

Taschenbuch